脏缩:高血压和心血管疾病的关键方法
1Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan. shinohara.keisuke.727@m.kyushu-u.ac.jp.
概括
在高血压模型中,选择性 afferent 损伤减少了同情活动,可能保护心脏免受损伤. 这种方法可能有利于心血管疾病患者,即使没有降低血压.
科学领域:
- 心血管科学 心血管科学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 高血压研究 高血压研究
背景情况:
- 交感性过度活动导致高血压和心血管疾病,如心力衰竭.
- 脏神经 (有fferent和efferent) 是血压和交感外流调节的关键.
- 之前的研究表明, afferent脏缩可以减少中心交感外流.
研究的目的:
- 在高血压和心力衰竭模型中审查损伤对交感活动和器官损伤的影响.
- 讨论临床证据,以脏缩在心血管疾病的好处,除了降低血压.
- 探索心血管疾病中脏缩的机制和临床效用.
主要方法:
- 动物研究的综述,包括达尔盐敏感小鼠与高血压心力衰竭.
- 对患有心血管疾病的患者损的临床研究的分析.
- 检查有关交感活动调节和器官保护的数据.
主要成果:
- 在没有显著降低血压的小鼠模型中,异性损减弱了心力衰竭的发展.
- 临床研究表明,脏缩可能会减少心血管事件和心房的发生率.
- 观察到损的心脏保护作用,可能是通过同情抑制,独立于抗高血压作用.
结论:
- 选择性 afferent 损伤显示有望通过减少交感活动来减轻心血管损伤.
- 脏皮可能为心血管疾病提供治疗益处,包括心力衰竭和心律失常,无论血压变化如何.
- 需要进一步的临床数据和基础研究,以充分确定疗效,并阐明心血管护理中脏缩的机制.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Neural Regulation of Blood Pressure
2.7K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.7K
Antihypertensive Drugs: Action of β1 Blockers
411
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
411
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
600
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
600
Antihypertensive Drugs: Direct Renin Inhibitors
546
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
546


